Performance measures for substance use disorders – what research is needed?

Addiction Science & Clinical Practice

Deborah W Garnick³  Constance M Horgan³  Andrea Acevedo³  Frank McCorry¹  Constance Weisner² 

[1] Chair, Washington Circle and FAM Consulting, Yorktown Heights, NY, USA

[2] Division of Research, Northern California Kaiser Permanente, University of California, San Francisco, CA, USA

[3] Institute for Behavioral Health, The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA

关键词: Electronic health records;    Structure;    Outcome;    Process;    Research agenda;    Performance measures;   

Others  :  789352
DOI  :  10.1186/1940-0640-7-18

 received in 2012-08-13, accepted in 2012-08-31,  发布年份 2012

【 摘 要 】

In 2010, the Washington Circle convened a meeting, supported by the National Institute on Drug Abuse (NIDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA), for a multidisciplinary group of experts to focus on the research gaps in performance measures for substance use disorders. This article presents recommendations in three areas: development of new performance measures; methodological and other considerations in using performance measures; and implementation research focused on using performance measures for accountability and quality improvement.

【 授权许可】

   
2012 Garnick et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Institute of Medicine: Medicare: A Strategy for Quality Assurance, Volume II. Washington, DC: National Academies Press; 1990.
• [2]Pincus HA, Spaeth-Rublee B, Watkins KE: Analysis & commentary: The case for measuring quality in mental health and substance abuse care. Health Aff Millwood 2011, 30(4):730-736.
• [3]The Washington Circle: The Washington Circle. http://www.washingtoncircle.org webcite
• [4]Institute of Medicine: Improving the Quality of Health Care for Mental Health and Substance Use Conditions. Washington, DC: National Academies Press; 2006.
• [5]Horgan C, Garnick DW: The quality of care for adults with mental and addictive disorders: Issues in performance measurement. Background paper for the Institute of Medicine Report "Improving the Quality of Health Care for Mental Health and Substance Use Conditions" 2005. http://sihp.brandeis.edu/ibh/pdfs/IOMJan05submitted.pdf webcite
• [6]McCarty D, McConnell KJ, Schmidt LA: Priorities for policy research on treatments for alcohol and drug use disorders. J Subst Abuse Treat 2010, 39(2):87-95.
• [7]National Quality Forum: National Voluntary Consensus Standards for the Treatment of Substance Use Conditions: Evidence-Based Treatment Practices—A Consensus Report. Washington, DC: National Quality Forum; 2007.
• [8]McGlynn EA: Choosing and evaluating clinical performance measures. The Joint Commission journal on quality improvement 1998, 24(9):470-479.
• [9]National Committee for Quality Assurance: Managed Behavioral Healthcare Organizations Accreditation. http://www.ncqa.org/tabid/94/Default.aspx webcite
• [10]The Joint Commission: Comprehensive Accreditation Manual for Behavioral Healthcare. Oakbrook Terrace, Illinois: Joint Commission Resources; 2011.
• [11]McConnell KJ, Hoffman KA, Quanbeck A, McCarty D: Management practices in substance abuse treatment programs. J Subst Abuse Treat 2009, 37(1):79-89.
• [12]Garnick DW, Lee MT, Chalk M, Gastfriend D, Horgan CM, McCorry F, McLellan AT, Merrick EL: Establishing the feasibility of performance measures for alcohol and other drugs. J Subst Abuse Treat 2002, 23(4):375-385.
• [13]Garnick DW, Lee MT, Horgan CM, Acevedo A: Washington Circle Public Sector W: Adapting Washington Circle performance measures for public sector substance abuse treatment systems. J Subst Abuse Treat 2009, 36(3):265-277.
• [14]Garnick DW, Lee MT, Horgan C, Acevedo A, Botticelli M, Clark S, Davis S, Gallati R, Haberlin K, Hanchett A, et al.: Lessons from five states: Public sector use of the Washington Circle performance measures. J Subst Abuse Treat 2011, 40(3):241-254.
• [15]National Committee for Quality Assurance: NCQA HEDIS. 2011. http://www.ncqa.org/tabid/1223/Default.aspx webcite
• [16]Harris AH, Humphreys K, Bowe T, Tiet Q, Finney JW: Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes? J Behav Health Serv Res 2010, 37(1):25-39.
• [17]Harris AH, Humphreys K, Finney JW: Veterans Affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness. J Subst Abuse Treat 2007, 33(4):333-339.
• [18]Hoffman KA, Ford JH, Choi D, Gustafson DH, McCarty D: Replication and sustainability of improved access and retention within the Network for the Improvement of Addiction Treatment. Drug Alcohol Depend 2008, 98(1–2):63-69.
• [19]McCarty D, Gustafson D, Capoccia VA, Cotter F: Improving care for the treatment of alcohol and drug disorders. J Behav Health Serv Res 2009, 36(1):52-60.
• [20]Capoccia VA, Cotter F, Gustafson DH, Cassidy EF, Ford JH, Madden L, Owens BH, Farnum SO, McCarty D, Molfenter T: Making "stone soup": improvements in clinic access and retention in addiction treatment. Jt Comm J Qual Patient Saf 2007, 33(2):95-103.
• [21]McCarty D, Gustafson DH, Wisdom JP, Ford J, Choi D, Molfenter T, Capoccia V, Cotter F: The Network for the Improvement of Addiction Treatment (NIATx): enhancing access and retention. Drug Alcohol Depend 2007, 88(2–3):138-145.
• [22]American Medical Association: Physician Consortium for Performance Improvement (PCPI). http://www.ama-assn.org/ama/pub/physician-resources/clinical-practice-improvement/clinical-quality/physician-consortium-performance-improvement.shtml webcite
• [23]Thomas CP, Garnick DW, Horgan CM, McCorry F, Gmyrek A, Chalk M, Gastfriend DR, Rinaldo SG, Albright J, Capoccia VA, et al.: Advancing performance measures for use of medications in substance abuse treatment. J Subst Abuse Treat 2011, 40(1):35-43.
• [24]Thomas CP, Horgan C, Garnick DW, et al.: A Standardized Measure for Assessing Use of Pharmacotherapy in Treating Substance Use Disorders: Rationale, Conceptualization and Pilot Test Results. Working manuscript; .
• [25]Fussell HE, Rieckmann TR, Quick MB: Medicaid reimbursement for screening and brief intervention for substance misuse. Psychiatr Serv 2011, 62(3):306-309.
• [26]Garnick DW, Horgan CM, Lee MT, Panas L, Ritter GA, Davis S, Leeper T, Moore R, Reynolds M: Are Washington Circle performance measures associated with decreased criminal activity following treatment? J Subst Abuse Treat 2007, 33(4):341-352.
• [27]Campbell KM: Impact of record-linkage methodology on performance indicators and multivariate relationships. J Subst Abuse Treat 2009, 36(1):110-117.
• [28]Garner BR, Godley MD, Funk RR, Lee MT, Garnick DW: The Washington Circle continuity of care performance measure: predictive validity with adolescents discharged from residential treatment. J Subst Abuse Treat 2010, 38(1):3-11.
• [29]Harris AH, Kivlahan DR, Bowe T, Finney JW, Humphreys K: Developing and validating process measures of health care quality: an application to alcohol use disorder treatment. Med Care 2009, 47(12):1244-1250.
• [30]Mant J: Process versus outcome indicators in the assessment of quality of health care. Int J Qual Health Care 2001, 13(6):475-480.
• [31]Rosenheck R, Kasprow W, Frisman L, Liu-Mares W: Cost-effectiveness of supported housing for homeless persons with mental illness. Arch Gen Psychiatry 2003, 60(9):940-951.
• [32]Rickards LD, McGraw SA, Araki L, Casey RJ, High CW, Hombs ME, Raysor RS: Collaborative initiative to help end chronic homelessness: introduction. J Behav Health Serv Res 2009, 37(2):149-166.
• [33]Kresky-Wolff M, Larson MJ, O'Brien RW, McGraw SA: Supportive housing approaches in the Collaborative Initiative to Help End Chronic Homelessness (CICH). J Behav Health Serv Res 2010, 37(2):213-225.
• [34]Gold M, Savage B, Sherman D: Joint Submission to the Ontario Ministry of Municipal Affairs and Housing Long-term Affordable Housing Consultation Session. 2009. http://www.camh.ca/en/hospital/about_camh/influencing_public_policy/public_policy_submissions/housing/Documents/Joint%20Housing%20Consultation%20Submission%20July%2022%2009.pdf webcite
• [35]Addiction Technology Transfer Center Network: The Shift to Recovery-Oriented Systems. http://www.nattc.org/learn/topics/rosc webcite
• [36]McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J: Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction 2005, 100(4):447-458.
• [37]Laudet AB: Building the science of recovery. 2009. http://www.nattc.org/learn/topics/rosc/docs/buildingthescience.pdf webcite
• [38]Dausey DJ, Pincus HA, Herrell JM: Performance measurement for co-occurring mental health and substance use disorders. Subst Abuse Treat Prev Policy 2009, 4:18. BioMed Central Full Text
• [39]Kilbourne AM, Farmer Teh C, Welsh D, Pincus HA, Lasky E, Perron B, Bauer MS: Implementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurement. Gen Hosp Psychiatry 2010, 32(6):636-643.
• [40]Hermann RC, Rollins CK, Chan JA: Risk-adjusting outcomes of mental health and substance-related care: a review of the literature. Harv Rev Psychiatry 2007, 15(2):52-69.
• [41]Nyweide DJ, Weeks WB, Gottlieb DJ, Casalino LP, Fisher ES: Relationship of primary care physicians' patient caseload with measurement of quality and cost performance. JAMA 2009, 302(22):2444-2450.
• [42]McLellan T: What is recovery? Revisiting the Betty Ford Institute Consensus Panel definition: The Betty Ford Consensus Panel and Consultants. J Subst Abuse Treat 2010, 38(2):200-201.
• [43]Betty Ford Institute Consensus P: What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat 2007, 33(3):221-228.
• [44]Ghitza U, Lindblad R, Gore-Langton RE, Sparenborg S, Tai B: Implication of Adopting Standardized Common Data Elements in Health IT Systems of Drug-Abuse Treatment Providers. In Poster presented in: College on Problems of Drug Dependence (CPDD) Annual Meeting: 2011. Hollywood, Florida; 2011.
• [45]Chan KS, Fowles JB, Weiner JP: Review: electronic health records and the reliability and validity of quality measures: a review of the literature. Med Care Res Rev 2010, 67(5):503-527.
• [46]Whitlock EP, Polen MR, Green CA, Orleans T, Klein J, Force USPST: Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004, 140(7):557-568.
• [47]Doty MM, Abrams MK, Hernandez SE, Stremikis K, Beal AC: Enhancing the Capacity of Community Health Centers to Achieve High Performance: Findings from the 2009. Commonwealth Fund National Survey of Federally Qualified Health Centers; 2010. http://www.commonwealthfund.org webcite
• [48]McDonald K, Schultz E, Albin L, Pineda N, Lonhart J, Sundaram V, Smith-Spangler C, Brustrom J, Malcolm E: Care Coordination Atlas Version 3 (Prepared by Stanford University under subcontract to Battelle on Contract No. 290-04-0020). AHRQ Publication No. 11-0023-EF 2010. http://www.ahrq.gov/qual/careatlas/careatlas.pdf webcite
• [49]Colton D: Strategies for implementing performance measurement in behavioural health care organisations. J Heal Manag 2007, 2007(3):301-316.
• [50]de Vos M, Graafmans W, Kooistra M, Meijboom B, Van Der Voort P, Westert G: Using quality indicators to improve hospital care: a review of the literature. Int J Qual Health Care 2009, 21(2):119-129.
• [51]Rosenthal MB, Dudley RA: Pay-for-performance: will the latest payment trend improve care? JAMA 2007, 297(7):740-744.
• [52]Honore PA, Simoes EJ, Moonesinghe R, Kirbey HC, Renner M: Applying principles for outcomes-based contracting in a public health program. J Public Health Manag Pract 2004, 10(5):451-457.
• [53]Amundson G, Solberg LI, Reed M, Martini EM, Carlson R: Paying for quality improvement: compliance with tobacco cessation guidelines. Jt Comm J Qual Saf 2003, 29(2):59-65.
• [54]Werner RM, Kolstad JT, Stuart EA, Polsky D: The effect of pay-for-performance in hospitals: lessons for quality improvement. Health Aff 2011, 30(4):690-698.
• [55]Christianson JB, Leatherman S, Sutherland K: Lessons from evaluations of purchaser pay-for-performance programs: a review of the evidence. Med Care Res Rev 2008, 65(6 Suppl):5S-35S.
• [56]Bremer RW, Scholle SH, Keyser D, Houtsinger JV, Pincus HA: Pay for performance in behavioral health. Psychiatr Serv 2008, 59(12):1419-1429.
• [57]McLellan AT, Kemp J, Brooks A, Carise D: Improving public addiction treatment through performance contracting: the Delaware experiment. Health Policy 2008, 87(3):296-308.
• [58]Stewart MT, Horgan CM, Garnick DW, Ritter G, McLellan AT: Performance contracting and quality improvement in outpatient treatment: Effects on waiting time and length of stay. J Subst Abuse Treat 2012. e-pub
• [59]Commons M, McGuire TG, Riordan MH: Performance contracting for substance abuse treatment. Health Serv Res 1997, 32(5):631-650.
• [60]Shen Y: Selection incentives in a performance-based contracting system. Health Serv Res 2003, 38(2):535-552.
• [61]Brucker DL, Stewart M: Performance-based contracting within a state substance abuse treatment system: a preliminary exploration of differences in client access and client outcomes. J Behav Health Serv Res 2011, 38(3):383-397.
• [62]Botticelli M: Designing P4P for substance abuse treatment in Massachusetts: Simulations of various reward structures 2009. In Presented in: 2009 Addictions Health Services Research Conference. San Francisco; 2009.
• [63]Activities AIC: Submission for OMB Review; Comment Request. Fed Regist 2011, 76:35454-35459.
• [64]Government Printing Office: Confidentiality of Alcohol and Drug Abuse Patient Records. Code of Federal Regulations Title 42, Volume 1, Chapter 1, Part 2. Washington, DC: Government Printing Office; 1975.
• [65]Department of Health and Human Services: Annual Progress Report to Congress: National Strategy for Quality Improvement in Health Care. 2012. http://www.ahrq.gov/workingforquality/nqs/nqs2012annlrpt.pdf webcite
• [66]Cotter F: Behavioral Health Quality Measures and Health Care Reform. In Presented in: SAAS/NIATx Conference: 2011. Boston; 2011.